Heparin neutralizing activity and coronary artery disease

Area of Science:

• Cardiovascular Medicine
• Hematology
• Biochemistry

Background:

• Platelet aggregation plays a crucial role in thrombosis and hemostasis.
• Dysfunctional platelet activity is implicated in the pathophysiology of coronary artery disease (CAD).
• The process of platelet aggregate disaggregation is not fully understood, particularly in disease states.

Purpose of the Study:

• To investigate the rate of adenosine diphosphate (ADP)-induced platelet aggregate disaggregation in men with and without coronary artery disease (CAD).
• To determine the relationship between platelet heparin neutralizing activity (HNA) release and the rate of platelet disaggregation.
• To explore potential mechanisms underlying impaired platelet function in CAD.

Main Methods:

• Studied ADP-induced platelet aggregation and disaggregation in platelet-rich plasma (PRP) from 32 men.
• Categorized participants into groups with and without CAD (21 with, 11 without).
• Measured the release of HNA from platelets during aggregation and correlated it with disaggregation rates.

Main Results:

• Slower platelet aggregate disaggregation (<10%) was observed more frequently in men with CAD.
• Platelets from men with slow disaggregation released significantly higher amounts of HNA (34-51%) compared to those with rapid disaggregation.
• A second phase of aggregation, with reduced light transmission, was noted in most PRP samples with rapid disaggregation.

Conclusions:

• Impaired disaggregation of ADP-induced platelet aggregates is more common in men with CAD.
• The release of HNA from platelets during aggregation may contribute to the inhibition of disaggregation.
• These findings suggest a potential role for HNA in the altered platelet dynamics observed in coronary artery disease.